Social Cognitive Training for Psychosis: Treatment Development

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01579422
Recruitment Status : Completed
First Posted : April 18, 2012
Last Update Posted : January 12, 2016
National Institute of Mental Health (NIMH)
Information provided by (Responsible Party):
Yale University

April 10, 2012
April 18, 2012
January 12, 2016
May 2012
August 2015   (Final data collection date for primary outcome measure)
social cognition [ Time Frame: change from baseline to approximately 6 weeks ]
AIHQ Eyes Task Hinting Task IPSAQ
Same as current
Complete list of historical versions of study NCT01579422 on Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
Social Cognitive Training for Psychosis: Treatment Development
Social Cognitive Training for Psychosis: Phase I Treatment Development

The primary aim of this proposal is to develop, refine, manualize and assess the feasibility and preliminary efficacy of a brief, narrowly-focused social cognitive intervention for individuals with psychosis. The intervention will focus on helping individuals interpret social situations, specifically the intentions and feelings of others.

Study methods include preliminary treatment and manual development based on series of uncontrolled cases, manual refinement, and a small feasibility/efficacy trial of the newly developed intervention.

Not Provided
Phase 1
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
  • Schizophrenia
  • Psychosis
Behavioral: social cognitive training
social cognitive training, 8-10 sessions
Experimental: social cognitive training
Intervention: Behavioral: social cognitive training
Not Provided

*   Includes publications given by the data provider as well as publications identified by Identifier (NCT Number) in Medline.
December 2015
August 2015   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  • Diagnosis of schizophrenia or other psychotic disorder
  • Age between 18 and 55
  • Psychiatrically stable
  • Clinician agrees to individual's participation in study
  • English as primary language

Exclusion Criteria:

  • current (past 30 days) symptoms of alcohol abuse/dependence
  • developmental disability
  • severe auditory/visual impairment or known neurological disorder
  • participant has a legal conservator
Sexes Eligible for Study: All
18 Years to 55 Years   (Adult)
Contact information is only displayed when the study is recruiting subjects
United States
1R34MH090109 ( U.S. NIH Grant/Contract )
Not Provided
Not Provided
Yale University
Yale University
National Institute of Mental Health (NIMH)
Not Provided
Yale University
January 2016

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP